Unknown is not the same as harmless.

Side effects in people remain unknown

The evidence check on September 28, 2026 found no human KPV data from which to establish its side effects. [a]

FDA, the US medicine regulator, found no KPV side-effect reports through December 2025 and no studies or published accounts of individual patients receiving KPV. [a]

With no patient studies or accounts of use, an empty list of harm reports cannot tell us how a person will respond.

Basic animal harm tests are missing too

FDA’s July 2026 review found no KPV studies of short-term or repeated-use toxicity, meaning harm caused by a substance. [a]

It also found no tests of effects on genes, pregnancy or cancer risk. [a]

This is different from a test finding no harm. The test itself was missing.

Product quality is another open question

FDA says KPV could prompt an immune response, meaning the body might react to it as a foreign substance. [a]

FDA also raised concerns about tiny units of KPV sticking together and unwanted substances in the product, with too little information to rule these risks out. [a]

There are no KPV patient data showing what symptoms these possible risks might cause. [a]

There is no FDA-reviewed list of who must avoid KPV

KPV has no FDA-reviewed label listing who must avoid it, how it might affect other medicines, or what happens in pregnancy. [a]

Do not fill that gap with a list from an advert. Bring your health history, medicines and questions to the person assessing your concern.